Elaine Caughey - Net Worth and Insider Trading

Elaine Caughey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elaine Caughey owns 1 companies in total, including Kymera Therapeutics Inc (KYMR) .

Click here to see the complete history of Elaine Caughey’s form 4 insider trades.

Insider Ownership Summary of Elaine Caughey

Ticker	Comapny	Transaction Date	Type of Owner
KYMR	Kymera Therapeutics Inc	2021-06-21	Chief Business Officer

Elaine Caughey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elaine Caughey Ownership Network

Ownership Network List of Elaine Caughey

No Data

Ownership Network Relation of Elaine Caughey

Elaine Caughey Owned Company Details

What does Kymera Therapeutics Inc do?

Who are the key executives at Kymera Therapeutics Inc?

Elaine Caughey is the Chief Business Officer of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Medical Officer Jared Gollob , Chief Operating Officer Jeremy G Chadwick , and 10 percent owner Atlas Venture Fund X, L.p. .

Kymera Therapeutics Inc (KYMR) Insider Trades Summary

Over the past 18 months, Elaine Caughey made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .

In summary, during the past 3 months, insiders sold 18,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 1 shares, with a net sale of 18,499 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kymera Therapeutics Inc Insider Transactions

No Available Data

Elaine Caughey Mailing Address

Above is the net worth, insider trading, and ownership report for Elaine Caughey. You might contact Elaine Caughey via mailing address: C/o Kymera Therapeutics, Inc., 200 Arsenal Yards, Suite 230, Watertown Ma 02472.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.